You are reading 1 of 2 free-access articles allowed for 30 days
The intention to develop the institute, which will be the first of its kind in Ireland, was announced in October by Trinity College Dublin (TCD) and St James’s Hospital, Dublin (SJH).
A business plan is currently under development and a joint development group has been established to lead planning of the facility, which will be located on the grounds of SJH.
A Trinity College spokesperson told MI that both it and SJH are making efforts to consolidate strengths in clinical and scientific research and confirmed the estimated cost for the facility at €120 million.
Approval by the boards of Trinity and SJH of the governance model for the cancer institute is to be followed by formal application to the Organisation of European Cancer Institutes (OECI) for accreditation review. This application will be submitted in June 2017, the spokesperson outlined.
They added that key appointments, funded with the use of internal resources, have been made or are in progress.
A post has been offered for the Chair in Translational Oncology, while the Chair in Cancer Nursing post is being progressed.
Prof David Gallagher has been appointed as Professor of Cancer Genetics/Oncology and Dr Patricia Doherty has taken up the role of Senior Research Programme Officer. Five lectureships in cancer themes are also planned.
A date for the opening of the institute has not been set, but will be part of the business plan development process, the spokesperson advised.
The aim is to develop a “comprehensive cancer centre, similar to best international exemplar models to deliver patient-centred care, setting a new standard for cancer care in Ireland”.
The institute aims to “decrease incidences of cancer and the cancer burden on people’s lives through integration of medicine and science in cancer prevention, treatment and survivorship”.
It also plans to educate the next generation of cancer researchers and clinicians, to equip them to deliver better outcomes for every patient, the spokesperson said.
Based on population changes, the incidence of cancer in Ireland will increase by 50 per cent in 2025 (compared with 2010) and by 100 per cent in 2040, according to estimates from the National Cancer Registry Ireland.